Moreover, the association of cyclophosphamide with a TLR9 agonist increases the chemokine expression in murine colon tumors (Ccl5, Cxcl9 and Cxcl10) and CD8 T-cell proportion and inhibits tumor growth [72]. Here, CD8A is linked to colonic neoplasm.